The content release includes the following updates:

4 new drugs in PharmaPendium

• Aceclidine Hydrochloride
• Sebetralstat
• Sepiapterin
• Sunvozertinib

FDA Approval Documents:

• 621 new FDA Approval Documents
• 7,474 new pages of FDA Approval Documents

FAERS:

• 387,318 new FAERS reports (2025_Q2)

The new totals for PharmaPendium are:

• 3,329,664 pages of FDA Approval documents (Including FDA Classic Collection)
• 167,436 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,043 drugs with data in PharmaPendium
• 3,062,046 extracted safety data lines
• 2,452,719 extracted PK data lines
• 681,912 extracted ME data lines
• 4,361,079 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 24,236,086 FAERS (post-marketing) reports
• 21,848 documents / 524,299 pages of EMA Approval documents
• 22,525 documents / 846,244 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

4 new drugs in PharmaPendium

• Amlodipine Besylate; Indapamide; Telmisartan
• Clesrovimab
• Covid-19 Vaccine, mRNA
• Taletrectinib Adipate

FDA Approval Documents:

• 844 new FDA Approval Documents
• 11,255 new pages of FDA Approval Documents

EMA Documents:

• 115 new EMA documents
• 3,119 new pages of EMA Documents

Extracted PK data observations:

• 3,383 new extracted PK data lines

Extracted Safety data observations:

• 7,100 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,003 new ME extracted data lines

Published Toxicity Database:

• 3,201 new safety records

The new totals for PharmaPendium are:

• 3,322,190 pages of FDA Approval documents (Including FDA Classic Collection)
• 166,815 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,039 drugs with data in PharmaPendium
• 3,062,046 extracted safety data lines
• 2,452,719 extracted PK data lines
• 681,912 extracted ME data lines
• 4,361,079 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,848,768 FAERS (post-marketing) reports
• 21,848 documents / 524,299 pages of EMA Approval documents
• 22,525 documents / 846,244 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

 FDA Approval Documents:

• 366 new FDA Approval Documents
• 7,312 new pages of FDA Approval Documents

EMA Documents:

• 128 new EMA documents
• 609 updated EMA documents
• 3,997 new pages of EMA Documents

Extracted PK data observations:

• 3,766 new extracted PK data lines

Extracted Safety data observations:

• 10,741 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,771 new ME extracted data lines

Published Toxicity Database:

• 2,906 new safety records

Efficacy Database:

• 28,758 new extracted data lines

The new totals for PharmaPendium are:

• 3,310,935 pages of FDA Approval documents (Including FDA Classic Collection)
• 165,971 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,035 drugs with data in PharmaPendium
• 3,051,745 extracted safety data lines
• 2,449,336 extracted PK data lines
• 679,909 extracted ME data lines
• 4,361,079 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,848,768 FAERS (post-marketing) reports
• 21,733 documents / 521,180 pages of EMA Approval documents
• 22,525 documents / 846,244 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

 5 new drugs in PharmaPendium

• Acoltremon
• Avutometinib Potassium; Defactinib Hydrochloride
• Prademagene Zamikeracel
• Revakinagene Taroretcel
• Telisotuzumab Vedotin

FDA Approval Documents:

• 244 new FDA Approval Documents
• 3,082 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 46 new FDA Advisory Committee Documents
• 1,751 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,303,623 pages of FDA Approval documents (Including FDA Classic Collection)
• 165,605 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,035 drugs with data in PharmaPendium
• 3,038,098 extracted safety data lines
• 2,445,570 extracted PK data lines
• 677,138 extracted ME data lines
• 4,332,321 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,848,767 FAERS (post-marketing) reports
• 21,605 documents / 517,183 pages of EMA Approval documents
• 22,525 documents / 846,244 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Linvoseltamab

FDA Approval Documents:

• 131 new FDA Approval Documents
• 1,448 new pages of FDA Approval Documents

EMA Documents:

• 281 new EMA documents
• 6,448 new pages of EMA Documents

 Extracted PK data observations:

• 2,515 new extracted PK data lines

 Extracted Safety data observations:

• 2,501 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,111 new ME extracted data lines

Published Toxicity Database:

• 3,691 new safety records

The new totals for PharmaPendium are:

• 3,300,541 pages of FDA Approval documents (Including FDA Classic Collection)
• 165,361 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,030 drugs with data in PharmaPendium
• 3,038,098 extracted safety data lines
• 2,445,570 extracted PK data lines
• 677,138 extracted ME data lines
• 4,332,321 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,848,767 FAERS (post-marketing) reports
• 21,605 documents / 517,183 pages of EMA Approval documents
• 22,479 documents / 844,493 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

 5 new drugs in PharmaPendium

• Atrasentan Hydrochloride
• Chikungunya Vaccine, Recombinant
• Diazoxide Choline
• Nipocalimab
• Penpulimab

FDA Approval Documents:

• 365 new FDA Approval Documents
• 4,831 new pages of FDA Approval Documents

FAERS:

• 394,558 new FAERS reports (2025_Q1 is added).

The new totals for PharmaPendium are:

• 3,299,093 pages of FDA Approval documents (Including FDA Classic Collection)
• 165,230 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,029 drugs with data in PharmaPendium
• 3,031,906 extracted safety data lines
• 2,443,055 extracted PK data lines
• 675,027 extracted ME data lines
• 4,332,321 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,848,932 FAERS (post-marketing) reports
• 21,324 documents / 510,735 pages of EMA Approval documents
• 22,479 documents / 844,493 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

 The content release includes the following updates:

 1 new drug in PharmaPendium 

• Garadacimab

FDA Approval Documents:

• 258 new FDA Approval Documents
• 4,032 new pages of FDA Approval Documents

EMA Documents:

• 182 new EMA documents
• 606 updated EMA documents
• 5,537 new pages of EMA Documents

Extracted PK data observations:

• 4,157 new extracted PK data lines

Extracted Safety data observations:

• 13,121 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,820 new ME extracted data lines

Published Toxicity Database:

• 5,145 new safety records

Efficacy Database:

• 28,956 new extracted data lines

The new totals for PharmaPendium are:

• 3,294,262 pages of FDA Approval documents (Including FDA Classic Collection)
• 164,865 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,024 drugs with data in PharmaPendium
• 3,031,906 extracted safety data lines
• 2,443,055 extracted PK data lines
• 675,027 extracted ME data lines
• 4,332,321 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,454,374 FAERS (post-marketing) reports
• 21,324 documents / 510,735 pages of EMA Approval documents
• 22,479 documents / 844,493 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Fitusiran
• Gepotidacin
• Kit for the Preparation of Gallium Ga 68 Gozetotide

FDA Approval Documents:

• 361 new FDA Approval Documents
• 4,138 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 13 new FDA Advisory Committee Documents
• 1,163 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,290,230 pages of FDA Approval documents (Including FDA Classic Collection)
• 164,607 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,023 drugs with data in PharmaPendium
• 3,013,640 extracted safety data lines
• 2,438,898 extracted PK data lines
• 672,207 extracted ME data lines
• 4,303,365 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,454,369 FAERS (post-marketing) reports
• 21,142 documents / 505,198 pages of EMA Approval documents
• 22,479 documents / 844,493 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

4 new drugs in PharmaPendium

• Mycobacterium Tuberculosis Derived Antigens
• Serplulimab
• Sipavibart
• Zapomeran

FDA Approval Documents:

• 253 new FDA Approval Documents
• 3,925 new pages of FDA Approval Documents

EMA Documents:

• 167 new EMA documents
• 6,383 new pages of EMA Documents

Extracted PK data observations:

• 5,829 new extracted PK data lines

Extracted Safety data observations:

• 4,597 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,317 new ME extracted data lines

Published Toxicity Database:

• 1,352 new safety records

The new totals for PharmaPendium are:

• 3,286,092 pages of FDA Approval documents (Including FDA Classic Collection)
• 164,246 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,020 drugs with data in PharmaPendium
• 3,013,640 extracted safety data lines
• 2,438,898 extracted PK data lines
• 672,207 extracted ME data lines
• 4,303,365 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,454,369 FAERS (post-marketing) reports
• 21,142 documents / 505,198 pages of EMA Approval documents
• 22,466 documents / 843,330 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

 The content release includes the following updates:

 4 new drugs in PharmaPendium

• Mirdametinib
• Nilotinib D-Tartrate
• Remestemcel-L-Rknd
• Vimseltinib

FDA Approval Documents:

• 454 new FDA Approval Documents
• 5,809 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,282,167 pages of FDA Approval documents (Including FDA Classic Collection)
• 163,993 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,016 drugs with data in PharmaPendium
• 3,007,691 extracted safety data lines
• 2,433,069 extracted PK data lines
• 668,890 extracted ME data lines
• 4,303,365 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,454,369 FAERS (post-marketing) reports
• 20,975 documents / 498,815 pages of EMA Approval documents
• 22,466 documents / 843,330 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Vilobelimab

FDA Approval Documents:

• 153 new FDA Approval Documents
• 2,543 new pages of FDA Approval Documents

EMA Documents:

• 116 new EMA documents
• 583 updated EMA documents
• 5,328 new pages of EMA Documents

Extracted PK data observations:

• 3,657 new extracted PK data lines

Extracted Safety data observations:

• 9,843 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,563 new ME extracted data lines

Published Toxicity Database:

• 4,931 new safety records

Efficacy Database:

• 39,205 new extracted data lines

The new totals for PharmaPendium are:

• 3,276,358 pages of FDA Approval documents (Including FDA Classic Collection)
• 163,539 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,012 drugs with data in PharmaPendium
• 3,007,691 extracted safety data lines
• 2,431,913 extracted PK data lines
• 668,888 extracted ME data lines
• 4,303,365 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,454,367 FAERS (post-marketing) reports
• 20,975 documents / 498,815 pages of EMA Approval documents
• 22,466 documents / 843,330 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Datopotamab Deruxtecan
• Meloxicam; Rizatriptan Benzoate
• Suzetrigine

FDA Approval Documents:

• 325 new FDA Approval Documents
• 5,949 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 113 new FDA Advisory Committee Documents
• 3,104 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,273,815 pages of FDA Approval documents (Including FDA Classic Collection)
• 163,386 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,011 drugs with data in PharmaPendium
• 2,992,917 extracted safety data lines
• 2,428,256 extracted PK data lines
• 667,325 extracted ME data lines
• 4,264,160 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,454,366 FAERS (post-marketing) reports
• 20,859 documents / 493,487 pages of EMA Approval documents
• 22,466 documents / 843,330 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 216 new FDA Approval Documents
• 2,704 new pages of FDA Approval Documents

EMA Documents:

• 82 new EMA documents
• 3,091 new pages of EMA Documents

Extracted PK data observations:

• 2,339 new extracted PK data lines

Extracted Safety data observations:

• 4,222 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,376 new ME extracted data lines

Published Toxicity Database:

• 3,743 new safety records

FAERS:

• 406,362 new FAERS reports (2024_Q4)

The new totals for PharmaPendium are:

• 3,267,866 pages of FDA Approval documents (Including FDA Classic Collection)
• 163,061 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,008 drugs with data in PharmaPendium
• 2,992,917 extracted safety data lines
• 2,426,838 extracted PK data lines
• 667,325 extracted ME data lines
• 4,264,160 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,454,363 FAERS (post-marketing) reports
• 20,859 documents / 493,487 pages of EMA Approval documents
• 22,353 documents / 840,226 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

10 new drugs in PharmaPendium

• Concizumab
• Cosibelimab
• Crinecerfont
• Deutivacaftor; Tezacaftor; Vanzacaftor Calcium
• Ensartinib Hydrochloride
• Nivolumab; Hyaluronidase
• Obecabtagene Autoleucel
• Olezarsen Sodium
• Pemetrexed Dipotassium
• Zenocutuzumab

FDA Approval Documents:

• 302 new FDA Approval Documents
• 4,616 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,265,162 pages of FDA Approval documents (Including FDA Classic Collection)
• 162,845 documents of FDA Approval documents (Including FDA Classic Collection)
• 5,008 drugs with data in PharmaPendium
• 2,984,952 extracted safety data lines
• 2,424,499 extracted PK data lines
• 665,949 extracted ME data lines
• 4,264,160 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,048,001 FAERS (post-marketing) reports
• 20,777 documents / 490,396 pages of EMA Approval documents
• 22,353 documents / 840,226 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Odronextamab
• Sugemalimab

FDA Approval Documents:

• 211 new FDA Approval Documents
• 3,043 new pages of FDA Approval Documents
• 87 new EMA documents
• 719 updated EMA documents
• 4,691 new pages of EMA Documents

Extracted PK data observations:

• 6,055 new extracted PK data lines

Extracted Safety data observations:

• 18,273 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,471 new ME extracted data lines

Published Toxicity Database:

• 15,953 new safety records

Efficacy Database:

• 68,111 new extracted data lines

The new totals for PharmaPendium are:

• 3,260,546 pages of FDA Approval documents (Including FDA Classic Collection)
• 162,543 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,998 drugs with data in PharmaPendium
• 2,995,052 extracted safety data lines
• 2,425,174 extracted PK data lines
• 666,148 extracted ME data lines
• 4,267,244 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,048,001 FAERS (post-marketing) reports
• 20,777 documents / 490,396 pages of EMA Approval documents
• 22,353 documents / 840,226 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2024.24 Release

The content release includes the following updates:

5 new drugs in PharmaPendium

• Acoramidis Hydrochloride
• Landiolol Hydrochloride
• Nilotinib Tartrate
• Revumenib Citrate
• Zanidatamab

FDA Approval Documents:

• 369 new FDA Approval Documents
• 5,195 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 122 new FDA Advisory Committee Documents
• 3,395 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,257,503 pages of FDA Approval documents (Including FDA Classic Collection)
• 162,332 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,996 drugs with data in PharmaPendium
• 2,960,826 extracted safety data lines
• 2,419,119 extracted PK data lines
• 662,677 extracted ME data lines
• 4,199,133 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,048,001 FAERS (post-marketing) reports
• 20,690 documents / 485,705 pages of EMA Approval documents
• 22,353 documents / 840,226 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Polihexanide

FDA Approval Documents:

• 241 new FDA Approval Documents
• 3,273 new pages of FDA Approval Documents

EMA Documents:

• 115 new EMA documents
• 3,511 new pages of EMA Documents

Extracted PK data observations:

• 6,763 new extracted PK data lines

Extracted Safety data observations:

• 4,324 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,612 new ME extracted data lines

Published Toxicity Database:

• 6,729 new safety records

The new totals for PharmaPendium are:

• 3,252,308 pages of FDA Approval documents (Including FDA Classic Collection)
• 161,963 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,991 drugs with data in PharmaPendium
• 2,960,826 extracted safety data lines
• 2,419,119 extracted PK data lines
• 662,677 extracted ME data lines
• 4,199,133 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,048,001 FAERS (post-marketing) reports
• 20,690 documents / 485,705 pages of EMA Approval documents
• 22,231 documents / 836,831 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates: 

5 new drugs in PharmaPendium

• Afamitresgene Autoleucel
• Foscarbidopa; Foslevodopa
• Inavolisib
• Marstacimab
• Sulopenem Etzadroxil; Probenecid

FDA Approval Documents:

• 575 new FDA Approval Documents
• 8,160 new pages of FDA Approval Documents

FAERS:

• 402,530 new FAERS reports (2024_Q3)

The new totals for PharmaPendium are:

• 3,249,035 pages of FDA Approval documents (Including FDA Classic Collection)
• 161,722 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,990 drugs with data in PharmaPendium
• 2,949,773 extracted safety data lines
• 2,412,356 extracted PK data lines
• 661,065 extracted ME data lines
• 4,199,133 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 23,048,001 FAERS (post-marketing) reports
• 20,575 documents / 482,194 pages of EMA Approval documents
• 22,231 documents / 836,831 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Delgocitinib
• Pegzilarginase
• Zolbetuximab

FDA Approval Documents:

• 228 new FDA Approval Documents
• 2,755 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 144 new FDA Advisory Committee Documents
• 3,741 new pages of FDA Advisory Committee Documents

EMA Documents:

• 218 new EMA documents
• 895 updated EMA documents
• 10,290 new pages of EMA Documents

Extracted PK data observations:

• 6,385 new extracted PK data lines

Extracted Safety data observations:

• 20,481 new extracted safety data lines

Metabolizing Enzymes Database:

• 3,971 new ME extracted data lines

Published Toxicity Database:

• 3,510 new safety records

Efficacy Database:

• 38,882 new extracted data lines

The new totals for PharmaPendium are:

• 3,240,875 pages of FDA Approval documents (Including FDA Classic Collection)
• 161,147 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,985 drugs with data in PharmaPendium
• 2,949,773 extracted safety data lines
• 2,412,356 extracted PK data lines
• 661,073 extracted ME data lines
• 4,199,133 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,645,471 FAERS (post-marketing) reports
• 20,575 documents / 482,194 pages of EMA Approval documents
• 22,231 documents / 836,831 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates: 

6 new drugs in PharmaPendium 

• Arimoclomol Citrate
• Atezolizumab; Hyaluronidase
• Flurpiridaz F 18
• Levacetylleucine
• Ocrelizumab; Hyaluronidase
• Xanomeline Tartrate; Trospium Chloride

FDA Approval Documents:

• 467 new FDA Approval Documents
• 6,219 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,238,120 pages of FDA Approval documents (Including FDA Classic Collection)
• 160,919 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,982 drugs with data in PharmaPendium
• 2,925,782 extracted safety data lines
• 2,405,971 extracted PK data lines
• 657,102 extracted ME data lines
• 4,160,251 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,645,471 FAERS (post-marketing) reports
• 20,357 documents / 471,904 pages of EMA Approval documents
• 22,087 documents / 833,090 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Dasatinib Monohydrate
• Paclitaxel Formulated as Albumin Bound Nanoparticles

FDA Approval Documents:

• 392 new FDA Approval Documents
• 5,634 new pages of FDA Approval Documents

EMA Documents:

• 155 new EMA documents
• 6,701 new pages of EMA Documents

Extracted PK data observations:

• 5,964 new extracted PK data lines

Extracted Safety data observations:

• 6,883 new extracted safety data lines

Metabolizing Enzymes Database:

• 4,263 new ME extracted data lines

Published Toxicity Database:

• 11,809 new safety records

The new totals for PharmaPendium are:

• 3,231,901 pages of FDA Approval documents (Including FDA Classic Collection)
• 160,452 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,976 drugs with data in PharmaPendium
• 2,925,782 extracted safety data lines
• 2,405,971 extracted PK data lines
• 657,102 extracted ME data lines
• 4,160,251 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,645,471 FAERS (post-marketing) reports
• 20,357 documents / 471,904 pages of EMA Approval documents
• 22,087 documents / 833,090 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

6 new drugs in PharmaPendium

• Axatilimab
• Lazertinib
• Nemolizumab
• Pneumococcal 21-Valent Conjugate Vaccine
• Seladelpar Lysine
• Vorasidenib

FDA Approval Documents:

• 242 new FDA Approval Documents
• 3,147 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,226,267 pages of FDA Approval documents (Including FDA Classic Collection)
• 160,060 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,974 drugs with data in PharmaPendium
• 2,907,090 extracted safety data lines
• 2,400,007 extracted PK data lines
• 652,839 extracted ME data lines
• 4,160,251 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,645,457 FAERS (post-marketing) reports
• 20,202 documents / 465,203 pages of EMA Approval documents
• 22,087 documents / 833,090 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Efanesoctocog Alfa

FDA Approval Documents:

• 528 new FDA Approval Documents
• 7,666 new pages of FDA Approval Documents
• 116 new EMA documents
• 513 updated EMA documents
• 5,965 new pages of EMA Documents

Extracted PK data observations:

• 3,587 new extracted PK data lines

Extracted Safety data observations:

• 14,225 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,401 new ME extracted data lines

Published Toxicity Database:

• 4,816 new safety records

Efficacy Database:

• 40,694 new extracted data lines

The new totals for PharmaPendium are:

• 3,223,120 pages of FDA Approval documents (Including FDA Classic Collection)
• 159,818 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,968 drugs with data in PharmaPendium
• 2,907,090 extracted safety data lines
• 2,400,007 extracted PK data lines
• 652,839 extracted ME data lines
• 4,160,251 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,645,457 FAERS (post-marketing) reports
• 20,194 documents / 465,123 pages of EMA Approval documents
• 22,087 documents / 833,090 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

6 new drugs in PharmaPendium

• Benzgalantamine
• Deuruxolitinib Phosphate
• Donanemab
• Ensifentrine
• Potassium Phosphates in Sodium Chloride
• Zoonotic Influenza Vaccine (H5N8) (Surface Antigen, Inactivated, Adjuvanted)

FDA Approval Documents:

• 260 new FDA Approval Documents
• 3,655 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 104 new FDA Advisory Committee Documents
• 1,737 new pages of FDA Advisory Committee Documents

FAERS:

• 393,903 new FAERS reports (2024_Q2)

The new totals for PharmaPendium are:

• 3,215,454 pages of FDA Approval documents (Including FDA Classic Collection)
• 159,290 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,967 drugs with data in PharmaPendium
• 2,888,049 extracted safety data lines
• 2,396,420 extracted PK data lines
• 650,438 extracted ME data lines
• 4,119,557 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,645,460 FAERS (post-marketing) reports
• 20,078 documents / 459,158 pages of EMA Approval documents
• 22,087 documents / 833,090 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Insulin Icodec
• Zoonotic Influenza Vaccine (H5N8) (Surface Antigen, Inactivated, Adjuvanted)

FDA Approval Documents:

• 321 new FDA Approval Documents
• 3,790 new pages of FDA Approval Documents

EMA Documents:

• 108 new EMA documents
• 5,841 new pages of EMA Documents

Extracted PK data observations:

• 2,750 new extracted PK data lines

Extracted Safety data observations:

• 7,938 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,738 new ME extracted data lines

Published Toxicity Database:

• 7,314 new safety records

The new totals for PharmaPendium are:

• 3,211,799 pages of FDA Approval documents (Including FDA Classic Collection)
• 159,030 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,960 drugs with data in PharmaPendium
• 2,888,049 extracted safety data lines
• 2,396,420 extracted PK data lines
• 650,438 extracted ME data lines
• 4,119,557 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,251,557 FAERS (post-marketing) reports
• 20,078 documents / 459,158 pages of EMA Approval documents
• 21,983 documents / 831,353 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

4 new drugs in PharmaPendium

• Crovalimab
• Elafibranor
• Imetelstat Sodium
• Sofpironium Bromide

FDA Approval Documents:

• 233 new FDA Approval Documents
• 3,285 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,208,009 pages of FDA Approval documents (Including FDA Classic Collection)
• 158,709 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,959 drugs with data in PharmaPendium
• 2,872,797 extracted safety data lines
• 2,393,670 extracted PK data lines
• 648,700 extracted ME data lines
• 4,120,305 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,251,557 FAERS (post-marketing) reports
• 19,970 documents / 453,317 pages of EMA Approval documents
• 21,983 documents / 831,353 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

2 new drugs in PharmaPendium

• Aztreonam; Avibactam Sodium
• Bevacizumab Gamma

FDA Approval Documents:

• 338 new FDA Approval Documents
• 4,196 new pages of FDA Approval Documents

EMA Documents:

• 131 new EMA documents
• 507 updated EMA documents
• 6,915 new pages of EMA Documents

Extracted PK data observations:

• 10,291 new extracted PK data lines

Extracted Safety data observations:

• 13,196 new extracted safety data lines

Metabolizing Enzymes Database:

• 7,789 new ME extracted data lines

Published Toxicity Database:

• 9,919 new safety records

Efficacy Database:

• 23,416 new extracted data lines

The new totals for PharmaPendium are:

• 3,204,724 pages of FDA Approval documents (Including FDA Classic Collection)
• 158,476 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,955 drugs with data in PharmaPendium
• 2,872,797 extracted safety data lines
• 2,393,730 extracted PK data lines
• 648,699 extracted ME data lines
• 4,120,305 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,251,557 FAERS (post-marketing) reports
• 19,970 documents / 453,317 pages of EMA Approval documents
• 21,983 documents / 831,353 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

4 new drugs in PharmaPendium

• Atidarsagene Autotemcel
• Fidanacogene Elaparvovec
• Lifileucel
• Tarlatamab

FDA Approval Documents:

• 359 new FDA Approval Documents
• 5,360 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 93 new FDA Advisory Committee Documents
• 2,069 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,200,528 pages of FDA Approval documents (Including FDA Classic Collection)
• 158,138 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,953 drugs with data in PharmaPendium
• 2,850,744 extracted safety data lines
• 2,383,439 extracted PK data lines
• 640,910 extracted ME data lines
• 4,096,889 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,251,557 FAERS (post-marketing) reports
• 19,839 documents / 446,402 pages of EMA Approval documents
• 21,983 documents / 831,353 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Danicopan

FDA Approval Documents:

• 626 new FDA Approval Documents
• 8,091 new pages of FDA Approval Documents

EMA Documents:

• 134 new EMA documents
• 6,281 new pages of EMA Documents

Extracted PK data observations:

• 5,474 new extracted PK data lines

Extracted Safety data observations:

• 4,319 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,449 new ME extracted data lines

Published Toxicity Database:

• 21,494 new safety records

FAERS:

• 400,978 new FAERS reports (2024_Q1).

The new totals for PharmaPendium are:

• 3,195,168 pages of FDA Approval documents (Including FDA Classic Collection)
• 157,779 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,949 drugs with data in PharmaPendium
• 2,849,682 extracted safety data lines
• 2,383,439 extracted PK data lines
• 640,910 extracted ME data lines
• 4,096,889 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 22,251,557 FAERS (post-marketing) reports
• 19,839 documents / 446,402 pages of EMA Approval documents
• 21,890 documents / 829,284 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

4 new drugs in PharmaPendium

• Mavorixafor
• Nogapendekin Alfa Inbakicept
• Pegulicianine
• Tovorafenib

FDA Approval Documents:

• 460 new FDA Approval Documents
• 6,541 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,187,077 pages of FDA Approval documents (Including FDA Classic Collection)
• 157,153 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,948 drugs with data in PharmaPendium
• 2,823,869 extracted safety data lines
• 2,377,965 extracted PK data lines
• 639,461 extracted ME data lines
• 4,096,889 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,850,579 FAERS (post-marketing) reports
• 19,705 documents / 440,121 pages of EMA Approval documents
• 21,890 documents / 829,284 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 456 new FDA Approval Documents
• 5,450 new pages of FDA Approval Documents

EMA Documents:

• 111 new EMA documents
• 579 updated EMA documents
• 4,116 new pages of EMA Documents

Extracted PK data observations:

• 6,970 new extracted PK data lines

Extracted Safety data observations:

• 18,170 new extracted safety data lines

Metabolizing Enzymes Database:

• 5,548 new ME extracted data lines

Published Toxicity Database:

• 299,231 new safety records (First set of Clinical Toxicity data is added.)

Efficacy Database:

• 34,271 new extracted data lines

The new totals for PharmaPendium are:

• 3,180,536 pages of FDA Approval documents (Including FDA Classic Collection)
• 156,693 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,944 drugs with data in PharmaPendium
• 2,824,062 extracted safety data lines
• 2,377,965 extracted PK data lines
• 639,471 extracted ME data lines
• 4,094,676 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,850,579 FAERS (post-marketing) reports
• 19,705 documents / 440,121 pages of EMA Approval documents
• 21,890 documents / 829,284 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

6 new drugs in PharmaPendium

• Aprocitentan
• Givinostat Hydrochloride
• Letibotulinumtoxina
• Macitentan; Tadalafil
• Resmetirom
• Sotatercept

FDA Approval Documents:

• 257 new FDA Approval Documents
• 3,367 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 76 new FDA Advisory Committee Documents
• 1,640 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

• 3,175,086 pages of FDA Approval documents (Including FDA Classic Collection)
• 156,237 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,944 drugs with data in PharmaPendium
• 2,506,661 extracted safety data lines
• 2,370,995 extracted PK data lines
• 633,923 extracted ME data lines
• 4,060,405 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,850,579 FAERS (post-marketing) reports
• 19,591 documents / 435,898 pages of EMA Approval documents
• 21,890 documents / 829,284 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 272 new FDA Approval Documents
• 3,682 new pages of FDA Approval Documents

EMA Documents:

• 87 new EMA documents
• 4,740 new pages of EMA Documents

Extracted PK data observations:

• 2,934 new extracted PK data lines

Extracted Safety data observations:

• 3,621 new extracted safety data lines

Metabolizing Enzymes Database:

• 1,196 new ME extracted data lines

Published Toxicity Database:

• 349 new safety records

The new totals for PharmaPendium are:

• 3,171,719 pages of FDA Approval documents (Including FDA Classic Collection)
• 155,980 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,938 drugs with data in PharmaPendium
• 2,506,661 extracted safety data lines
• 2,370,995 extracted PK data lines
• 633,923 extracted ME data lines
• 4,060,405 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,850,579 FAERS (post-marketing) reports
• 19,591 documents / 435,898 pages of EMA Approval documents
• 21,814 documents / 827,644 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Cefepime; Enmetazobactam
• Exagamglogene Autotemcel
• Lovotibeglogene Autotemcel

FDA Approval Documents:

• 264 new FDA Approval Documents
• 3,908 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

• 3,168,037 pages of FDA Approval documents (Including FDA Classic Collection)
• 155,708 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,938 drugs with data in PharmaPendium
• 2,502,691 extracted safety data lines
• 2,368,061 extracted PK data lines
• 632,727 extracted ME data lines
• 4,060,405 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,850,579 FAERS (post-marketing) reports
• 19,504 documents / 431,158 pages of EMA Approval documents
• 21,814 documents / 827,644 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

1 new drug in PharmaPendium

• Palopegteriparatide

FDA Approval Documents:

• 354 new FDA Approval Documents
• 4,680 new pages of FDA Approval Documents

EMA Documents:

• 146 new EMA documents
• 648 updated EMA documents
• 9,237 new pages of EMA Documents

Extracted PK data observations:

• 7,408 new extracted PK data lines

Extracted Safety data observations:

• 12,358 new extracted safety data lines

Metabolizing Enzymes Database:

• 4,922 new ME extracted data lines

Published Toxicity Database:

• 401 new safety records

Efficacy Database:

• 44,674 new extracted data lines

The new totals for PharmaPendium are:

• 3,164,129 pages of FDA Approval documents (Including FDA Classic Collection)
• 155,444 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,935 drugs with data in PharmaPendium
• 2,502,705 extracted safety data lines
• 2,368,065 extracted PK data lines
• 632,727 extracted ME data lines
• 4,060,405 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,850,579 FAERS (post-marketing) reports
• 19,505 documents / 431,191 pages of EMA Approval documents
• 21,814 documents / 827,644 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

• Adamts13, Recombinant
• Berdazimer Sodium
• Chikungunya Vaccine, Live

FDA Approval Documents:

• 304 new FDA Approval Documents
• 4,822 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

• 17 new FDA Advisory Committee Documents
• 2,221 new pages of FDA Advisory Committee Documents

FAERS:

• 412,212 new FAERS reports (2023_Q4)

The new totals for PharmaPendium are:

• 3,159,449 pages of FDA Approval documents (Including FDA Classic Collection)
• 155,090 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,934 drugs with data in PharmaPendium
• 2,489,946 extracted safety data lines
• 2,360,657 extracted PK data lines
• 627,805 extracted ME data lines
• 4,015,731 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,850,579 FAERS (post-marketing) reports
• 19,359 documents / 421,954 pages of EMA Approval documents
• 21,814 documents / 827,644 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

FDA Approval Documents:

• 227 new FDA Approval Documents
• 3,156 new pages of FDA Approval Documents

EMA Documents:

• 95 new EMA documents
• 3,389 new pages of EMA Documents

Extracted PK data observations:

• 6,895 new extracted PK data lines

Extracted Safety data observations:

• 4,268 new extracted safety data lines

Metabolizing Enzymes Database:

• 2,128 new ME extracted data lines

Published Toxicity Database:

• 706 new safety records

The new totals for PharmaPendium are:

• 3,154,627 pages of FDA Approval documents (Including FDA Classic Collection)
• 154,786 documents of FDA Approval documents (Including FDA Classic Collection)
• 4,931 drugs with data in PharmaPendium
• 2,489,381 extracted safety data lines
• 2,360,657 extracted PK data lines
• 627,805 extracted ME data lines
• 4,015,731 extracted Efficacy data lines
• 184,226 extracted Activity data lines
• 21,438,367 FAERS (post-marketing) reports
• 19,359 documents / 421,954 pages of EMA Approval documents
• 21,797 documents / 825,423 pages of FDA Advisory Committees Meetings documents
• 10,906 documents / 308,149 pages of FDA Classic Collection
• 2,769 documents / 32,290 pages of DESI documents